课题基金 / 基金详情

Expression of BMP family proteins in mammalian cells and production of monoclonal antibodies

Expression of BMP family proteins in mammalian cells and production of monoclonal antibodies
BMP家族蛋白在哺乳动物细胞中的表达和单克隆抗体的生产
批准号:
02558017
负责人:
UENO Naoto
金额:
$6.85万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1992

项目摘要

项目成果

UENO Naoto的其他基金

相似基金

相关文献

中文摘要
翻译
以大鼠激活素βA基因为探针,筛选了非洲爪哇基因组DNA文库。我们已经分离到5个独立的基因,其中一个基因被发现编码与哺乳动物激活素密切相关的蛋白。有趣的是,该基因的其余部分含有哺乳动物骨形态发生蛋白的两栖对应蛋白,该蛋白是根据它们在体内诱导异位骨形成的能力而提纯的。最终,我们分离了非洲爪哇BMP-2、-4和-7的cDNA。为了获得纯净的BMP蛋白并为实验和临床研究提供依据,我们尝试在哺乳动物细胞中表达BMP蛋白。我们发现,将BMP-4基因导入含有PSD(X)表达载体的CHO细胞中,表达效率较高(20ug/L)。另一方面,我们成功地制备了抗骨形态发生蛋白-2多肽和β-半乳糖苷酶/骨形态发生蛋白融合蛋白的多克隆抗体。前者抗体(Ab383)与BMP-4和BMP-2反应,后者(Ab97)与BMP-4特异。根据其免疫反应性,我们对在CHO细胞中表达的BMP-4进行了部分纯化。最终制备的重组非洲爪哇BMP-2在生化和生物学上与哺乳动物BMP-2几乎没有区别。因此,非洲爪哇BMPs被认为是一种很有前途的分子,用于开发治疗骨折和骨质疏松症的药物。此外,我们的抗体被证明是有用的筛选牛骨提取物中的BMPs。
英文摘要
We have screened a genomic DNA library of Xenopus laevis with rat activin betaA gene as a probe. We have isolated 5 independent genes and one of the genes was found to be encoding a protein closely related to mammalian activin. Interestingly, the rest of the gene contained an amphibian counterpart of mammalian bone morphogenetic proteins, which was purified based on their ability to induce ectopic bone formation in vivo. Eventually, we isolated cDNAs of Xenopus BMP-2,-4 and -7. In order to obtain pure BMP proteins and supply them for experimental and clinical studies, we tried to express BMP proteins in mamalian cells. We have found that expression rate is relatively high(20 ug/L) when BMP-4 cDNA is introduced into CHO cells with pSD(X) expression vector. On the other hand, we successfully raised polyclonal antibodies against BMP-2 peptide and beta-galactosidase/BMP-4 fusion protein. The former antibody (Ab383) was found to react with BMP-4 as well as BMP-2 and the latter (Ab97) was specific to BMP-4. We partially purified the BMP-4 expressed in CHO cells based on its immunoreactivity. The final preparation of the recombinant Xenopus BMP-Xenopus BMP-2 has been shown be indistinguishable from mammalian BMP-2 biochemically ann biologically. Therefore, Xenopus BMPs are thought to be a promising molecule to develop drugs for bone fracture and osteoporosis. In addition, our antibodies are demonstrated to be useful to screen BMPs in the extract of bovine bone.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
N.Ueno: "Mesoderm induction in early amphibian embryos by activin A and its related gene products in Xenopus laevis" 3rd international symposia “frontiers of muscle research",Uehara Memorial Science Foundation.
N.Ueno:“非洲爪蟾中激活素 A 及其相关基因产物对早期两栖动物胚胎的中胚层诱导”,第三届国际研讨会“肌肉研究前沿”,上原纪念科学基金会。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ueno,N.: "Identification of Bone Morphogenetic Protein-2 in Early Xenopus laevis Embryos" Growth Factors.
Ueno,N.:“早期非洲爪蟾胚胎中骨形态发生蛋白 2 的鉴定”生长因子。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 24 条
    Development of methodologies to study Aiptasia-Symbiodinium symbiosis
    • 批准号:
      25650087
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.66万
    • 财政年份:
      2013
    • 负责人:
      UENO Naoto
    • 依托单位:
    Identification of the biological significance of small chemicals for morphogenesis
    • 批准号:
      24370092
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2012
    • 负责人:
      UENO Naoto
    • 依托单位:
    Significance of membrane/protein trafficking for the establishment of cell polarity in the vertebrate
    • 批准号:
      21370102
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2009
    • 负责人:
      UENO Naoto
    • 依托单位:
    Clarification of cell polarity formation mechanism in archenteron formation
    • 批准号:
      17207015
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.28万
    • 财政年份:
      2005
    • 负责人:
      UENO Naoto
    • 依托单位:
    海外基金